We are live on
!
Find out more
BFA
BlackRock Fund Advisors Portfolio holdings
AUM
$542B
1-Year Est. Return
18.13%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$355B
AUM Growth
+$17.7B
(+5.2%)
Cap. Flow
+$3.38B
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
9.86%
Holding
4,000
New
139
Increased
1,720
Reduced
1,849
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$405M |
| 2 |
Wells Fargo
WFC
|
+$296M |
| 3 |
GE Aerospace
GE
|
+$146M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$136M |
| 5 |
TIME
Time Inc.
TIME
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$199M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$191M |
| 3 |
Apple
AAPL
|
+$173M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$169M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.61% |
| 2 | Healthcare | 12.54% |
| 3 | Financials | 12.33% |
| 4 | Industrials | 11.48% |
| 5 | Energy | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
UFP Technologies
UFPT
$1.97B
| $3.64M | ﹤0.01% |
151,217
-8,789
| -5% | -$219K |
|
3002
1-800-Flowers.com
FLWS
$252M
| $3.63M | ﹤0.01% |
626,772
-94,848
| -13% | -$532K |
|
3003
Enphase Energy
ENPH
$4.62B
| $3.63M | ﹤0.01% |
425,054
-26,785
| -6% | -$217K |
|
|
EMCI
3004
DELISTED
EMC INS Group Inc
EMCI
| $3.62M | ﹤0.01% |
176,361
-11,990
| -6% | -$261K |
|
3005
Travelzoo
TZOO
$76.7M
| $3.62M | ﹤0.01% |
186,993
-39,344
| -17% | -$752K |
|
3006
Malibu Boats
MBUU
$548M
| $3.61M | ﹤0.01% |
179,792
-45,272
| -20% | -$933K |
|
|
NSTG
3007
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.61M | ﹤0.01% |
241,411
+221,457
| +1,110% | +$3.49M |
|
3008
Ameresco
AMRC
$980M
| $3.6M | ﹤0.01% |
511,771
-48,417
| -9% | -$328K |
|
|
ASXC
3009
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.59M | ﹤0.01% |
+54,736
| New | +$3.16M |
|
3010
TechTarget
TTGT
$327M
| $3.58M | ﹤0.01% |
405,937
+70,757
| +21% | +$520K |
|
|
AMBR
3011
DELISTED
Amber Road Inc
AMBR
| $3.54M | ﹤0.01% |
+219,792
| New | +$3.15M |
|
|
MSO
3012
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
| $3.54M | ﹤0.01% |
754,361
+48,217
| +7% | +$208K |
|
|
NGD
3013
DELISTED
New Gold Inc
NGD
| $3.54M | ﹤0.01% |
556,291
-7,198
| -1% | -$38.8K |
|
|
GTT
3014
DELISTED
GTT Communications, Inc.
GTT
| $3.54M | ﹤0.01% |
+346,705
| New | +$3.62M |
|
|
STCN
3015
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $3.54M | ﹤0.01% |
101,362
-8,364
| -8% | -$304K |
|
|
MRTX
3016
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.53M | ﹤0.01% |
+176,550
| New | +$3.41M |
|
3017
Actinium Pharmaceuticals
ATNM
$26.3M
| $3.52M | ﹤0.01% |
+16,249
| New | +$5.41M |
|
3018
Preformed Line Products
PLPC
$1.39B
| $3.52M | ﹤0.01% |
65,333
-6,314
| -9% | -$361K |
|
|
ZU
3019
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $3.51M | ﹤0.01% |
85,728
-2,045
| -2% | -$82.3K |
|
|
VITC
3020
DELISTED
VITACOST COM INC COM STK (DE)
VITC
| $3.5M | ﹤0.01% |
559,335
-55,677
| -9% | -$362K |
|
3021
Tandem Diabetes Care
TNDM
$1.27B
| $3.49M | ﹤0.01% |
21,443
-4,448
| -17% | -$757K |
|
3022
Tempest Therapeutics
TPST
$14.3M
| $3.48M | ﹤0.01% |
130
+16
| +14% | +$377K |
|
3023
Q2 Holdings
QTWO
$3.78B
| $3.47M | ﹤0.01% |
+243,586
| New | +$3.3M |
|
3024
Immunic
IMUX
$178M
| $3.47M | ﹤0.01% |
+318
| New | +$2.23M |
|
|
MVNR
3025
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
| $3.47M | ﹤0.01% |
228,947
+80,955
| +55% | +$1.18M |
|
Similar funds
BIT
BG
BA
BIM
BJ
IC
EAM
MFS
BlackRock Fund Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Fund Advisors held 4,000 positions worth $355B, up 5.2% from $337B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
BlackRock Fund Advisors's Q2 2014 filing shows 139 new, 1,720 increased, 1,849 reduced and 134 closed positions. Its largest new stake was Endo International plc: 6,053,196 shares worth $424M. The largest sale was Pentair, an estimated $199M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- BlackRock Fund Advisors's largest Q2 2014 buy was Endo International plc: 6,053,196 shares worth $424M.
- BlackRock Fund Advisors added most to Wells Fargo in Q2 2014, an estimated $296M increase.
- BlackRock Fund Advisors's biggest Q2 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $191M.
- BlackRock Fund Advisors fully exited Pentair in Q2 2014, selling an estimated $199M.
- BlackRock Fund Advisors's ten largest holdings make up 9.9% of its $355B portfolio in Q2 2014.
- BlackRock Fund Advisors opened 139 new positions and closed 134 in Q2 2014.
- BlackRock Fund Advisors's portfolio value rose 5.2% quarter-over-quarter to $355B.
Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.